Key result
ADA screening criteria for silent CHD lack reported quantitative results in type 2 diabetes.
Why the study?
What is the proportion of type 2 diabetes patients satisfying ADA screening criteria and the prevalence of silent coronary heart disease in this population?
Observational (n=2,226)
No
What is the proportion of type 2 diabetes patients satisfying ADA screening criteria and the prevalence of silent coronary heart disease in this population?
ADA criteria utility for silent CHD in T2D remains unproven; leaves open need for prospective validation before screening adoption.
Patients with type 2 diabetes suffer twice the cardiovascular mortality of patients without the disease (1,2). In 1998, the American Diabetes Association (ADA) published guidelines for early detection of coronary heart disease (CHD) in asymptomatic patients with diabetes, with a specific focus on patients with multiple cardiovascular risk factors (3). Patients that fulfill any criteria are to be further risk stratified with stress testing. The criteria include 1 ) typical or atypical cardiac symptoms; 2 ) resting electrocardiograph suggestive of ischemia or infarction; 3 ) peripheral or carotid occlusive disease; 4 ) sedentary lifestyle, aged ≥35 years, and plans to begin a vigorous exercise program; and 5 ) more than two of the following risk factors in addition to diabetes: total cholesterol ≥240 mg/dl, LDL cholesterol ≥160 m/dl, or HDL cholesterol 140/90 mmHg; smoking; family history of premature coronary artery disease; or micro-/macroalbuminuria. However, there are limited data available evaluating the performance of these guidelines in a clinical setting. We determined the proportion of patients in our clinic with type 2 diabetes that satisfied the ADA screening criteria and prevalence of CHD in these patients using stress testing and cardiac catheterization. In 1999, records of patients ( n = 2,226) in the Joslin Center at the University of Maryland Medical Center …
No takes yet. Share an insight, caveat, or question.
Kharlip et al. (2006) conducted an observational in Type 2 diabetes (n=2,226). ADA screening criteria for coronary heart disease was evaluated on Proportion of patients satisfying ADA screening criteria and prevalence of CHD. ADA screening criteria for silent coronary heart disease were evaluated in 2,226 patients with type 2 diabetes, though quantitative results are not reported in the truncated abstract.